89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,488,481 | -15.0% | 161,171 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $2,928,798 | +260.0% | 154,554 | +189.3% | 0.00% | – |
| Q1 2023 | $813,648 | +28691.5% | 53,424 | +23964.9% | 0.00% | – |
| Q4 2022 | $2,826 | +182.6% | 222 | +22.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 182 | +219.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 57 | -59.6% | 0.00% | – |
| Q1 2022 | $1,000 | -97.9% | 141 | -96.1% | 0.00% | – |
| Q4 2021 | $48,000 | +2300.0% | 3,652 | +2869.1% | 0.00% | – |
| Q2 2021 | $2,000 | -96.7% | 123 | -95.1% | 0.00% | – |
| Q1 2021 | $60,000 | -87.6% | 2,532 | -87.2% | 0.00% | – |
| Q4 2020 | $483,000 | +355.7% | 19,826 | +381.8% | 0.00% | – |
| Q3 2020 | $106,000 | +30.9% | 4,115 | +1.6% | 0.00% | – |
| Q2 2020 | $81,000 | +22.7% | 4,052 | +54.3% | 0.00% | – |
| Q1 2020 | $66,000 | +1000.0% | 2,626 | +998.7% | 0.00% | – |
| Q4 2019 | $6,000 | – | 239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |